Position
Chief Executive Officer
Company
Veristat
Description
Veristat has announced that Kim McLean Boericke has been named as the new Chief Executive Officer, succeeding Patrick Flanagan. Boericke, who was previously the Chief Operating Officer, will lead the company in its mission to innovate and grow in the clinical research sector.
Quick answer
Veristat Appoints Kim McLean Boericke as Chief Executive Officer (January 13, 2026). Veristat is based in Southborough, Massachusetts, United States.
- Who is the new Chief Executive Officer at Veristat?
- Veristat named Kim McLean Boericke Chief Executive Officer, announced January 13, 2026.
- What did Veristat announce on January 13, 2026?
- Veristat has announced that Kim McLean Boericke has been named as the new Chief Executive Officer, succeeding Patrick Flanagan. Boericke, who was previously the Chief Operating Officer, will lead the company in its mission to innovate and grow in the clinical research sector.
- What does Veristat do?
- Veristat is the science-first full-service drug and biologic CRO and consultancy that integrates strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel...
- Where is Veristat based?
- Veristat is based in Southborough, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- BioMarin Pharmaceutical (January 12, 2026), Flashpoint Therapeutics (January 14, 2026), HaemaLogiX (January 15, 2026) and Emmecell (January 16, 2026) also announced leadership changes within 45 days of Veristat.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- BioMarin Appoints Arpit Davé as Chief Digital and Information Officer (January 12, 2026)
- Flashpoint Therapeutics Appoints Venkat R. Krishnamurthy as Chief Scientific Officer (January 14, 2026)
- HaemaLogiX Appoints Dr Chris Baldwin as Chief Executive Officer (January 15, 2026)
- Emmecell Appoints Ramin Valian as Chief Executive Officer (January 16, 2026)
- Spyre Therapeutics Appoints Kate Tansey Chevlen as Chief Commercial Officer (January 17, 2026)
- Enara Bio Appoints Scott Drutman as Chief Medical Officer (January 8, 2026)
Who to call at Veristat, and when
A new leader at Veristat brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Veristat raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Veristat, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Veristat. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Veristat changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Veristat changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.